Remove Contamination Remove Drug Delivery Remove Manufacturing
article thumbnail

Mitigating the risks of cross-contamination during Oral Solid Dose (OSD) manufacturing

Pharmaceutical Technology

While the industry is seeing advances in alternative drug delivery systems, oral solid doses, such as pills, capsules and soft gels, remain at the forefront of the industry. Tablet manufacturing, which is the most common OSD form, takes an API dry powder ingredient and compresses it to form tablets, which can be coated or uncoated.

article thumbnail

Flexible grinding processes for sterile nanopharmaceutical manufacturing

Pharmaceutical Technology

Nano-based delivery systems are on the rise, as they enable manufacturers to deliver therapeutic agents to specific targeted tissue in a more controlled manner. Data indicates that the global nanopharmaceutical drugs market size reached USD 53.85 Billion in 2021 and is expected to reach USD 102.4 Billion in 2030.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Prefilled syringes and vaccines: Optimising parenteral packaging for the next pandemic

Pharmaceutical Technology

When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. To boost the profitability of the drug at a later stage in its lifecycle, manufacturers may then consider changing the presentation to prefilled syringes. Lowering extractables levels .

Packaging 130
article thumbnail

A Biodegradable Nanocellulose ECG Patch: The Sustainable Alternative

XTalks

The healthcare industry has one of the heaviest environmental footprints, and manufacturers are increasingly faced with regulations to make more sustainable products,” said Mohammad H. Unfortunately, about 91 percent of this plastic waste from healthcare is not recycled and either ends up in landfills or contaminates natural environments.

article thumbnail

STAT+: Pharmalittle: Moderna must face patent claims over its Covid-19 vaccine; Pfizer and BioNTech testing combo Covid and flu shot

STAT News

The companies allege Moderna’s vaccine uses their technology for a drug-delivery system without permission. Citing Lilly announced earlier this year that the creation of its proposed manufacturing campus would create 300 permanent jobs once operational as well as 500 jobs during the construction phase.

Vaccine 97
article thumbnail

Going big: How cartridges are making large-volume, high-dose subcutaneous autoinjectors a reality

Pharmaceutical Technology

But with the advent of injection site absorption enhancers, drug delivery device innovations, as well as the recent primary container options, the practical subcutaneous self-administration of large-volume parenterals is becoming possible. For them, intravenous infusion in a hospital setting is the only option. References 1.

Protein 130
article thumbnail

Injecting Innovation: The Rising Trend of Autoinjectors in Modern Medicine

Roots Analysis

The continuous evolution of autoinjectors reflects a significant shift towards empowering patients to take control of their treatment, ensuring timely and accurate medication delivery for better health management. In January 2024, Rx Bandz signed a manufacturing agreement with Weiss-Aug for their MiniJect autoinjector.